首页> 美国卫生研究院文献>The Scientific World Journal >Evaluation of Task Shifting in Community-Based DOTS Program as an Effective Control Strategy for Tuberculosis
【2h】

Evaluation of Task Shifting in Community-Based DOTS Program as an Effective Control Strategy for Tuberculosis

机译:评估基于社区的DOTS计划中的任务转移作为结核病的有效控制策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tuberculosis (TB) remains to be the most prevalent and debilitating pulmonary (PTB) infection in the world today, affecting about one-third of the world's population. TB is an endemic disease in many developing countries, and efforts at eliminating the disease remain futile. While the course of the disease is indolent with years of latency, the reactivation of the disease can pose serious pulmonary and systemic infections that compromise multiple organ functions which lead to respiratory failure or end-organ damage. Despite attempts to control and eradicate the mycobacterium, the prevalence of the disease remains high due to increasing population rate, persistence of poverty and poor health care, treatment failure, increasing multidrug resistance as a consequence of treatment failure and poor compliance, and existence of comorbid conditions that compromise immune response. Limited government resources to screen and monitor disease progression of TB in third world countries hamper the eradication of the disease. In response, we have evaluated the efficiency and effectivity of a Community-Based Directly Observed Treatment, Short-Course (CB-DOTS), which is an equally effective alternative strategy to health center DOTS.
机译:肺结核(TB)仍然是当今世界上最流行,最使人衰弱的肺部(PTB)感染,影响了世界三分之一的人口。结核病是许多发展中国家的地方病,因此消除结核病的努力仍是徒劳的。尽管该病的病程伴随着数年的潜伏期而变得轻而易举,但该病的再激活可能会导致严重的肺部和全身感染,损害多器官功能,从而导致呼吸衰竭或终末器官损害。尽管尝试控制和根除分枝杆菌,但由于人口增加,贫穷和医疗保健的持续存在,治疗失败,由于治疗失败和依从性差而导致的多药耐药性增加以及存在共病,该疾病的流行率仍然很高损害免疫反应的条件。在第三世界国家,用于筛查和监测结核病疾病进展的政府资源有限,阻碍了该病的根除。作为回应,我们评估了以社区为基础的直接观察治疗短期课程(CB-DOTS)的效率和有效性,这是与卫生院DOTS等效的替代策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号